Zobrazeno 1 - 2
of 2
pro vyhledávání: '"N. J. Van Blijderveen"'
Autor:
V. Dezentje, N. J. Van Blijderveen, H. Gelderblom, H. Putter, M. P. Van Herk-Sukel, M. K. Casparie, A. C. Egberts, J. W. Nortier, H. J. Guchelaar
Publikováno v:
Journal of Clinical Oncology. 27:CRA509-CRA509
CRA509 Background: The use of cytochrome P450 2D6 inhibiting drugs (CYP2D6 inhibitors) during tamoxifen treatment leads to a decrease in plasma concentration of endoxifen, the major active tamoxifen metabolite. Concomitant use of CYP2D6 inhibitors, s
Autor:
Mariel K. Casparie, N. J. Van Blijderveen, Antoine C. G. Egberts, J.W.R. Nortier, Hein Putter, H-J Guchelaar, M. P. Van Herk-Sukel, Hans Gelderblom, Vincent O. Dezentjé
Publikováno v:
Journal of Clinical Oncology. 27:CRA509-CRA509
CRA509 Background: The use of cytochrome P450 2D6 inhibiting drugs (CYP2D6 inhibitors) during tamoxifen treatment leads to a decrease in plasma concentration of endoxifen, the major active tamoxifen metabolite. Concomitant use of CYP2D6 inhibitors, s